You are here

  • Home
  • Archive
  • Volume 75, Issue 2
  • Randomised, double-blind, multicentre, mixed-methods, dose-escalation feasibility trial of mirtazapine for better treatment of severe breathlessness in advanced lung disease (BETTER-B feasibility)

Citation Tools

Article menu
Brief communication
Randomised, double-blind, multicentre, mixed-methods, dose-escalation feasibility trial of mirtazapine for better treatment of severe breathlessness in advanced lung disease (BETTER-B feasibility)

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Higginson IJ, Wilcock A, Johnson MJ on behalf of BETTER-B Feasibility Trial Group, et al
Randomised, double-blind, multicentre, mixed-methods, dose-escalation feasibility trial of mirtazapine for better treatment of severe breathlessness in advanced lung disease (BETTER-B feasibility)
Thorax 2020;75:176-179.